$ISBG While the Company has frequently commented on the demand growth it has seen in its CBD products segment, ISBG has not discussed its growing home healthcare services segment as a core strategic and operational factor. However, this segment has shown steady and robust top line growth on a sequential month-over-month basis in both total patients and total sales so far in 2019, and the Company expects this trend to continue and potentially accelerate in the months and quarters ahead.

https://www.barrons.com/press-release/PR-CO-2...90?tesla=y